Global Precision Medicine Market research
Global Precision Medicine Market research

Precision Medicine Comprehensive Study by Type (Consumables, Instruments, Services, Others), Application (Diagnostics, Therapeutics, Pharmaceuticals, Medical Devices, Others), End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, Healthcare, IT/Big Data Companies), Technology (Genomics, Transcriptomics, Epigenomics), Sequencing (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing, Nanopore Sequencing) Players and Region - Global Market Outlook to 2024

Precision Medicine Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 10.7%  

Jun 2019 Edition 237 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Precision Medicine Market Overview:
Precision Medicine is refer to customization of medical treatment by genetic understanding of the patients. It is use to analyze cause of disease at molecular level. New technologies in precision medicine market like genome sequencing, targeted sequencing and continuous research and development owing to increasing number of cancer and rare diseases growing the market. In addition development in personalized treatment, cost- effective therapies are projected to drive the sales potentially over forecast period. According to AMA, the Global Precision Medicine market is expected to see growth rate of 10.7%

Market Drivers
  • Growing incidence of cancer and rare diseases
  • Increasing Use of Big Data in Healthcare
  • Rising Demand of Personalized Treatment

Market Trend
  • Growing cost-effective genomic and molecular biology testing techniques

Restraints
  • Stringent Healthcare Reforms

Opportunities
  • Growing Research in Big Pharma and Biotech Companies

Challenges
  • Intense Competition among the vendors


Competitive Landscape:
Number of players are present in market hence market is fragmented. But growing research and development, new product launches, clinical trials, increasing ageing population, government initiatives for private companies are expected to grow market potentially over the forecast period.
Some of the key players profiled in the report are Biocrates Life Sciences AG (Austria), Nanostring Technologies (United States), Intomics (Denmark), Pfizer Inc. (united States), Eagle Genomics Ltd (United Kingdom), Teva Pharmaceuticals (Israel), Laboratory Corporation of America Holdings (United States), Novartis AG (Switzerland), Qiagen NV (Netherlands), Quest Diagnostics Incorporated (United States) and F. Hoffmann-La Roche AG (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like Medtronic (Dublin). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Precision Medicine market by 2024. Considering Market by End User , the sub-segment i.e. Diagnostic Tool companies will boost the Precision Medicine market. Considering Market by Technology , the sub-segment i.e. Genomics will boost the Precision Medicine market. Considering Market by Sequencing, the sub-segment i.e. Sequencing by Synthesis will boost the Precision Medicine market.

Market Highlights:

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Precision Medicine market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Precision Medicine market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT/ Big Data Companies, Clinical Laboratories, Business Entities, Government Bodies, Business Research and consulting Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Consumables
  • Instruments
  • Services
  • Others
By Application
  • Diagnostics
  • Therapeutics
  • Pharmaceuticals
  • Medical Devices
  • Others
By End User
  • Diagnostic Tool companies
  • Pharma & Biotech Companies
  • Clinical Laboratories
  • Healthcare
  • IT/Big Data Companies

By Technology
  • Genomics
  • Transcriptomics
  • Epigenomics

By Sequencing
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing incidence of cancer and rare diseases
      • 3.2.2. Increasing Use of Big Data in Healthcare
      • 3.2.3. Rising Demand of Personalized Treatment
    • 3.3. Market Challenges
      • 3.3.1. Intense Competition among the vendors
    • 3.4. Market Trends
      • 3.4.1. Growing cost-effective genomic and molecular biology testing techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Precision Medicine, by Type, Application, End User , Technology , Sequencing and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Precision Medicine (Value)
      • 5.2.1. Global Precision Medicine by: Type (Value)
        • 5.2.1.1. Consumables
        • 5.2.1.2. Instruments
        • 5.2.1.3. Services
        • 5.2.1.4. Others
      • 5.2.2. Global Precision Medicine by: Application (Value)
        • 5.2.2.1. Diagnostics
        • 5.2.2.2. Therapeutics
        • 5.2.2.3. Pharmaceuticals
        • 5.2.2.4. Medical Devices
        • 5.2.2.5. Others
      • 5.2.3. Global Precision Medicine by: Sequencing (Value)
        • 5.2.3.1. Sequencing by Synthesis
        • 5.2.3.2. Ion Semiconductor Sequencing
        • 5.2.3.3. Sequencing by Ligation
        • 5.2.3.4. Pyrosequencing
        • 5.2.3.5. Single Molecule Real Time Sequencing
        • 5.2.3.6. Chain Termination Sequencing
        • 5.2.3.7. Nanopore Sequencing
      • 5.2.4. Global Precision Medicine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Precision Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Biocrates Life Sciences AG (Austria)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nanostring Technologies (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Intomics (Denmark)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (united States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eagle Genomics Ltd (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teva Pharmaceuticals (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Laboratory Corporation of America Holdings (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novartis AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Qiagen NV (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Quest Diagnostics Incorporated (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Precision Medicine Sale, by Type, Application, End User , Technology , Sequencing and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Precision Medicine (Value)
      • 7.2.1. Global Precision Medicine by: Type (Value)
        • 7.2.1.1. Consumables
        • 7.2.1.2. Instruments
        • 7.2.1.3. Services
        • 7.2.1.4. Others
      • 7.2.2. Global Precision Medicine by: Application (Value)
        • 7.2.2.1. Diagnostics
        • 7.2.2.2. Therapeutics
        • 7.2.2.3. Pharmaceuticals
        • 7.2.2.4. Medical Devices
        • 7.2.2.5. Others
      • 7.2.3. Global Precision Medicine by: Sequencing (Value)
        • 7.2.3.1. Sequencing by Synthesis
        • 7.2.3.2. Ion Semiconductor Sequencing
        • 7.2.3.3. Sequencing by Ligation
        • 7.2.3.4. Pyrosequencing
        • 7.2.3.5. Single Molecule Real Time Sequencing
        • 7.2.3.6. Chain Termination Sequencing
        • 7.2.3.7. Nanopore Sequencing
      • 7.2.4. Global Precision Medicine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Precision Medicine: by Type(USD Million)
  • Table 2. Precision Medicine Consumables , by Region USD Million (2013-2018)
  • Table 3. Precision Medicine Instruments , by Region USD Million (2013-2018)
  • Table 4. Precision Medicine Services , by Region USD Million (2013-2018)
  • Table 5. Precision Medicine Others , by Region USD Million (2013-2018)
  • Table 6. Precision Medicine: by Application(USD Million)
  • Table 7. Precision Medicine Diagnostics , by Region USD Million (2013-2018)
  • Table 8. Precision Medicine Therapeutics , by Region USD Million (2013-2018)
  • Table 9. Precision Medicine Pharmaceuticals , by Region USD Million (2013-2018)
  • Table 10. Precision Medicine Medical Devices , by Region USD Million (2013-2018)
  • Table 11. Precision Medicine Others , by Region USD Million (2013-2018)
  • Table 12. Precision Medicine: by Sequencing(USD Million)
  • Table 13. Precision Medicine Sequencing by Synthesis , by Region USD Million (2013-2018)
  • Table 14. Precision Medicine Ion Semiconductor Sequencing , by Region USD Million (2013-2018)
  • Table 15. Precision Medicine Sequencing by Ligation , by Region USD Million (2013-2018)
  • Table 16. Precision Medicine Pyrosequencing , by Region USD Million (2013-2018)
  • Table 17. Precision Medicine Single Molecule Real Time Sequencing , by Region USD Million (2013-2018)
  • Table 18. Precision Medicine Chain Termination Sequencing , by Region USD Million (2013-2018)
  • Table 19. Precision Medicine Nanopore Sequencing , by Region USD Million (2013-2018)
  • Table 20. South America Precision Medicine, by Country USD Million (2013-2018)
  • Table 21. South America Precision Medicine, by Type USD Million (2013-2018)
  • Table 22. South America Precision Medicine, by Application USD Million (2013-2018)
  • Table 23. South America Precision Medicine, by End User USD Million (2013-2018)
  • Table 24. South America Precision Medicine, by Technology USD Million (2013-2018)
  • Table 25. South America Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 26. Brazil Precision Medicine, by Type USD Million (2013-2018)
  • Table 27. Brazil Precision Medicine, by Application USD Million (2013-2018)
  • Table 28. Brazil Precision Medicine, by End User USD Million (2013-2018)
  • Table 29. Brazil Precision Medicine, by Technology USD Million (2013-2018)
  • Table 30. Brazil Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 31. Argentina Precision Medicine, by Type USD Million (2013-2018)
  • Table 32. Argentina Precision Medicine, by Application USD Million (2013-2018)
  • Table 33. Argentina Precision Medicine, by End User USD Million (2013-2018)
  • Table 34. Argentina Precision Medicine, by Technology USD Million (2013-2018)
  • Table 35. Argentina Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 36. Rest of South America Precision Medicine, by Type USD Million (2013-2018)
  • Table 37. Rest of South America Precision Medicine, by Application USD Million (2013-2018)
  • Table 38. Rest of South America Precision Medicine, by End User USD Million (2013-2018)
  • Table 39. Rest of South America Precision Medicine, by Technology USD Million (2013-2018)
  • Table 40. Rest of South America Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 41. Asia Pacific Precision Medicine, by Country USD Million (2013-2018)
  • Table 42. Asia Pacific Precision Medicine, by Type USD Million (2013-2018)
  • Table 43. Asia Pacific Precision Medicine, by Application USD Million (2013-2018)
  • Table 44. Asia Pacific Precision Medicine, by End User USD Million (2013-2018)
  • Table 45. Asia Pacific Precision Medicine, by Technology USD Million (2013-2018)
  • Table 46. Asia Pacific Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 47. China Precision Medicine, by Type USD Million (2013-2018)
  • Table 48. China Precision Medicine, by Application USD Million (2013-2018)
  • Table 49. China Precision Medicine, by End User USD Million (2013-2018)
  • Table 50. China Precision Medicine, by Technology USD Million (2013-2018)
  • Table 51. China Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 52. Japan Precision Medicine, by Type USD Million (2013-2018)
  • Table 53. Japan Precision Medicine, by Application USD Million (2013-2018)
  • Table 54. Japan Precision Medicine, by End User USD Million (2013-2018)
  • Table 55. Japan Precision Medicine, by Technology USD Million (2013-2018)
  • Table 56. Japan Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 57. India Precision Medicine, by Type USD Million (2013-2018)
  • Table 58. India Precision Medicine, by Application USD Million (2013-2018)
  • Table 59. India Precision Medicine, by End User USD Million (2013-2018)
  • Table 60. India Precision Medicine, by Technology USD Million (2013-2018)
  • Table 61. India Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 62. South Korea Precision Medicine, by Type USD Million (2013-2018)
  • Table 63. South Korea Precision Medicine, by Application USD Million (2013-2018)
  • Table 64. South Korea Precision Medicine, by End User USD Million (2013-2018)
  • Table 65. South Korea Precision Medicine, by Technology USD Million (2013-2018)
  • Table 66. South Korea Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 67. Taiwan Precision Medicine, by Type USD Million (2013-2018)
  • Table 68. Taiwan Precision Medicine, by Application USD Million (2013-2018)
  • Table 69. Taiwan Precision Medicine, by End User USD Million (2013-2018)
  • Table 70. Taiwan Precision Medicine, by Technology USD Million (2013-2018)
  • Table 71. Taiwan Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 72. Australia Precision Medicine, by Type USD Million (2013-2018)
  • Table 73. Australia Precision Medicine, by Application USD Million (2013-2018)
  • Table 74. Australia Precision Medicine, by End User USD Million (2013-2018)
  • Table 75. Australia Precision Medicine, by Technology USD Million (2013-2018)
  • Table 76. Australia Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 77. Rest of Asia-Pacific Precision Medicine, by Type USD Million (2013-2018)
  • Table 78. Rest of Asia-Pacific Precision Medicine, by Application USD Million (2013-2018)
  • Table 79. Rest of Asia-Pacific Precision Medicine, by End User USD Million (2013-2018)
  • Table 80. Rest of Asia-Pacific Precision Medicine, by Technology USD Million (2013-2018)
  • Table 81. Rest of Asia-Pacific Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 82. Europe Precision Medicine, by Country USD Million (2013-2018)
  • Table 83. Europe Precision Medicine, by Type USD Million (2013-2018)
  • Table 84. Europe Precision Medicine, by Application USD Million (2013-2018)
  • Table 85. Europe Precision Medicine, by End User USD Million (2013-2018)
  • Table 86. Europe Precision Medicine, by Technology USD Million (2013-2018)
  • Table 87. Europe Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 88. Germany Precision Medicine, by Type USD Million (2013-2018)
  • Table 89. Germany Precision Medicine, by Application USD Million (2013-2018)
  • Table 90. Germany Precision Medicine, by End User USD Million (2013-2018)
  • Table 91. Germany Precision Medicine, by Technology USD Million (2013-2018)
  • Table 92. Germany Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 93. France Precision Medicine, by Type USD Million (2013-2018)
  • Table 94. France Precision Medicine, by Application USD Million (2013-2018)
  • Table 95. France Precision Medicine, by End User USD Million (2013-2018)
  • Table 96. France Precision Medicine, by Technology USD Million (2013-2018)
  • Table 97. France Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 98. Italy Precision Medicine, by Type USD Million (2013-2018)
  • Table 99. Italy Precision Medicine, by Application USD Million (2013-2018)
  • Table 100. Italy Precision Medicine, by End User USD Million (2013-2018)
  • Table 101. Italy Precision Medicine, by Technology USD Million (2013-2018)
  • Table 102. Italy Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 103. United Kingdom Precision Medicine, by Type USD Million (2013-2018)
  • Table 104. United Kingdom Precision Medicine, by Application USD Million (2013-2018)
  • Table 105. United Kingdom Precision Medicine, by End User USD Million (2013-2018)
  • Table 106. United Kingdom Precision Medicine, by Technology USD Million (2013-2018)
  • Table 107. United Kingdom Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 108. Netherlands Precision Medicine, by Type USD Million (2013-2018)
  • Table 109. Netherlands Precision Medicine, by Application USD Million (2013-2018)
  • Table 110. Netherlands Precision Medicine, by End User USD Million (2013-2018)
  • Table 111. Netherlands Precision Medicine, by Technology USD Million (2013-2018)
  • Table 112. Netherlands Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 113. Rest of Europe Precision Medicine, by Type USD Million (2013-2018)
  • Table 114. Rest of Europe Precision Medicine, by Application USD Million (2013-2018)
  • Table 115. Rest of Europe Precision Medicine, by End User USD Million (2013-2018)
  • Table 116. Rest of Europe Precision Medicine, by Technology USD Million (2013-2018)
  • Table 117. Rest of Europe Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 118. MEA Precision Medicine, by Country USD Million (2013-2018)
  • Table 119. MEA Precision Medicine, by Type USD Million (2013-2018)
  • Table 120. MEA Precision Medicine, by Application USD Million (2013-2018)
  • Table 121. MEA Precision Medicine, by End User USD Million (2013-2018)
  • Table 122. MEA Precision Medicine, by Technology USD Million (2013-2018)
  • Table 123. MEA Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 124. Middle East Precision Medicine, by Type USD Million (2013-2018)
  • Table 125. Middle East Precision Medicine, by Application USD Million (2013-2018)
  • Table 126. Middle East Precision Medicine, by End User USD Million (2013-2018)
  • Table 127. Middle East Precision Medicine, by Technology USD Million (2013-2018)
  • Table 128. Middle East Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 129. Africa Precision Medicine, by Type USD Million (2013-2018)
  • Table 130. Africa Precision Medicine, by Application USD Million (2013-2018)
  • Table 131. Africa Precision Medicine, by End User USD Million (2013-2018)
  • Table 132. Africa Precision Medicine, by Technology USD Million (2013-2018)
  • Table 133. Africa Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 134. North America Precision Medicine, by Country USD Million (2013-2018)
  • Table 135. North America Precision Medicine, by Type USD Million (2013-2018)
  • Table 136. North America Precision Medicine, by Application USD Million (2013-2018)
  • Table 137. North America Precision Medicine, by End User USD Million (2013-2018)
  • Table 138. North America Precision Medicine, by Technology USD Million (2013-2018)
  • Table 139. North America Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 140. United States Precision Medicine, by Type USD Million (2013-2018)
  • Table 141. United States Precision Medicine, by Application USD Million (2013-2018)
  • Table 142. United States Precision Medicine, by End User USD Million (2013-2018)
  • Table 143. United States Precision Medicine, by Technology USD Million (2013-2018)
  • Table 144. United States Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 145. Canada Precision Medicine, by Type USD Million (2013-2018)
  • Table 146. Canada Precision Medicine, by Application USD Million (2013-2018)
  • Table 147. Canada Precision Medicine, by End User USD Million (2013-2018)
  • Table 148. Canada Precision Medicine, by Technology USD Million (2013-2018)
  • Table 149. Canada Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 150. Mexico Precision Medicine, by Type USD Million (2013-2018)
  • Table 151. Mexico Precision Medicine, by Application USD Million (2013-2018)
  • Table 152. Mexico Precision Medicine, by End User USD Million (2013-2018)
  • Table 153. Mexico Precision Medicine, by Technology USD Million (2013-2018)
  • Table 154. Mexico Precision Medicine, by Sequencing USD Million (2013-2018)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Precision Medicine: by Type(USD Million)
  • Table 167. Precision Medicine Consumables , by Region USD Million (2019-2024)
  • Table 168. Precision Medicine Instruments , by Region USD Million (2019-2024)
  • Table 169. Precision Medicine Services , by Region USD Million (2019-2024)
  • Table 170. Precision Medicine Others , by Region USD Million (2019-2024)
  • Table 171. Precision Medicine: by Application(USD Million)
  • Table 172. Precision Medicine Diagnostics , by Region USD Million (2019-2024)
  • Table 173. Precision Medicine Therapeutics , by Region USD Million (2019-2024)
  • Table 174. Precision Medicine Pharmaceuticals , by Region USD Million (2019-2024)
  • Table 175. Precision Medicine Medical Devices , by Region USD Million (2019-2024)
  • Table 176. Precision Medicine Others , by Region USD Million (2019-2024)
  • Table 177. Precision Medicine: by Sequencing(USD Million)
  • Table 178. Precision Medicine Sequencing by Synthesis , by Region USD Million (2019-2024)
  • Table 179. Precision Medicine Ion Semiconductor Sequencing , by Region USD Million (2019-2024)
  • Table 180. Precision Medicine Sequencing by Ligation , by Region USD Million (2019-2024)
  • Table 181. Precision Medicine Pyrosequencing , by Region USD Million (2019-2024)
  • Table 182. Precision Medicine Single Molecule Real Time Sequencing , by Region USD Million (2019-2024)
  • Table 183. Precision Medicine Chain Termination Sequencing , by Region USD Million (2019-2024)
  • Table 184. Precision Medicine Nanopore Sequencing , by Region USD Million (2019-2024)
  • Table 185. South America Precision Medicine, by Country USD Million (2019-2024)
  • Table 186. South America Precision Medicine, by Type USD Million (2019-2024)
  • Table 187. South America Precision Medicine, by Application USD Million (2019-2024)
  • Table 188. South America Precision Medicine, by End User USD Million (2019-2024)
  • Table 189. South America Precision Medicine, by Technology USD Million (2019-2024)
  • Table 190. South America Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 191. Brazil Precision Medicine, by Type USD Million (2019-2024)
  • Table 192. Brazil Precision Medicine, by Application USD Million (2019-2024)
  • Table 193. Brazil Precision Medicine, by End User USD Million (2019-2024)
  • Table 194. Brazil Precision Medicine, by Technology USD Million (2019-2024)
  • Table 195. Brazil Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 196. Argentina Precision Medicine, by Type USD Million (2019-2024)
  • Table 197. Argentina Precision Medicine, by Application USD Million (2019-2024)
  • Table 198. Argentina Precision Medicine, by End User USD Million (2019-2024)
  • Table 199. Argentina Precision Medicine, by Technology USD Million (2019-2024)
  • Table 200. Argentina Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 201. Rest of South America Precision Medicine, by Type USD Million (2019-2024)
  • Table 202. Rest of South America Precision Medicine, by Application USD Million (2019-2024)
  • Table 203. Rest of South America Precision Medicine, by End User USD Million (2019-2024)
  • Table 204. Rest of South America Precision Medicine, by Technology USD Million (2019-2024)
  • Table 205. Rest of South America Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 206. Asia Pacific Precision Medicine, by Country USD Million (2019-2024)
  • Table 207. Asia Pacific Precision Medicine, by Type USD Million (2019-2024)
  • Table 208. Asia Pacific Precision Medicine, by Application USD Million (2019-2024)
  • Table 209. Asia Pacific Precision Medicine, by End User USD Million (2019-2024)
  • Table 210. Asia Pacific Precision Medicine, by Technology USD Million (2019-2024)
  • Table 211. Asia Pacific Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 212. China Precision Medicine, by Type USD Million (2019-2024)
  • Table 213. China Precision Medicine, by Application USD Million (2019-2024)
  • Table 214. China Precision Medicine, by End User USD Million (2019-2024)
  • Table 215. China Precision Medicine, by Technology USD Million (2019-2024)
  • Table 216. China Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 217. Japan Precision Medicine, by Type USD Million (2019-2024)
  • Table 218. Japan Precision Medicine, by Application USD Million (2019-2024)
  • Table 219. Japan Precision Medicine, by End User USD Million (2019-2024)
  • Table 220. Japan Precision Medicine, by Technology USD Million (2019-2024)
  • Table 221. Japan Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 222. India Precision Medicine, by Type USD Million (2019-2024)
  • Table 223. India Precision Medicine, by Application USD Million (2019-2024)
  • Table 224. India Precision Medicine, by End User USD Million (2019-2024)
  • Table 225. India Precision Medicine, by Technology USD Million (2019-2024)
  • Table 226. India Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 227. South Korea Precision Medicine, by Type USD Million (2019-2024)
  • Table 228. South Korea Precision Medicine, by Application USD Million (2019-2024)
  • Table 229. South Korea Precision Medicine, by End User USD Million (2019-2024)
  • Table 230. South Korea Precision Medicine, by Technology USD Million (2019-2024)
  • Table 231. South Korea Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 232. Taiwan Precision Medicine, by Type USD Million (2019-2024)
  • Table 233. Taiwan Precision Medicine, by Application USD Million (2019-2024)
  • Table 234. Taiwan Precision Medicine, by End User USD Million (2019-2024)
  • Table 235. Taiwan Precision Medicine, by Technology USD Million (2019-2024)
  • Table 236. Taiwan Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 237. Australia Precision Medicine, by Type USD Million (2019-2024)
  • Table 238. Australia Precision Medicine, by Application USD Million (2019-2024)
  • Table 239. Australia Precision Medicine, by End User USD Million (2019-2024)
  • Table 240. Australia Precision Medicine, by Technology USD Million (2019-2024)
  • Table 241. Australia Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 242. Rest of Asia-Pacific Precision Medicine, by Type USD Million (2019-2024)
  • Table 243. Rest of Asia-Pacific Precision Medicine, by Application USD Million (2019-2024)
  • Table 244. Rest of Asia-Pacific Precision Medicine, by End User USD Million (2019-2024)
  • Table 245. Rest of Asia-Pacific Precision Medicine, by Technology USD Million (2019-2024)
  • Table 246. Rest of Asia-Pacific Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 247. Europe Precision Medicine, by Country USD Million (2019-2024)
  • Table 248. Europe Precision Medicine, by Type USD Million (2019-2024)
  • Table 249. Europe Precision Medicine, by Application USD Million (2019-2024)
  • Table 250. Europe Precision Medicine, by End User USD Million (2019-2024)
  • Table 251. Europe Precision Medicine, by Technology USD Million (2019-2024)
  • Table 252. Europe Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 253. Germany Precision Medicine, by Type USD Million (2019-2024)
  • Table 254. Germany Precision Medicine, by Application USD Million (2019-2024)
  • Table 255. Germany Precision Medicine, by End User USD Million (2019-2024)
  • Table 256. Germany Precision Medicine, by Technology USD Million (2019-2024)
  • Table 257. Germany Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 258. France Precision Medicine, by Type USD Million (2019-2024)
  • Table 259. France Precision Medicine, by Application USD Million (2019-2024)
  • Table 260. France Precision Medicine, by End User USD Million (2019-2024)
  • Table 261. France Precision Medicine, by Technology USD Million (2019-2024)
  • Table 262. France Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 263. Italy Precision Medicine, by Type USD Million (2019-2024)
  • Table 264. Italy Precision Medicine, by Application USD Million (2019-2024)
  • Table 265. Italy Precision Medicine, by End User USD Million (2019-2024)
  • Table 266. Italy Precision Medicine, by Technology USD Million (2019-2024)
  • Table 267. Italy Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 268. United Kingdom Precision Medicine, by Type USD Million (2019-2024)
  • Table 269. United Kingdom Precision Medicine, by Application USD Million (2019-2024)
  • Table 270. United Kingdom Precision Medicine, by End User USD Million (2019-2024)
  • Table 271. United Kingdom Precision Medicine, by Technology USD Million (2019-2024)
  • Table 272. United Kingdom Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 273. Netherlands Precision Medicine, by Type USD Million (2019-2024)
  • Table 274. Netherlands Precision Medicine, by Application USD Million (2019-2024)
  • Table 275. Netherlands Precision Medicine, by End User USD Million (2019-2024)
  • Table 276. Netherlands Precision Medicine, by Technology USD Million (2019-2024)
  • Table 277. Netherlands Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 278. Rest of Europe Precision Medicine, by Type USD Million (2019-2024)
  • Table 279. Rest of Europe Precision Medicine, by Application USD Million (2019-2024)
  • Table 280. Rest of Europe Precision Medicine, by End User USD Million (2019-2024)
  • Table 281. Rest of Europe Precision Medicine, by Technology USD Million (2019-2024)
  • Table 282. Rest of Europe Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 283. MEA Precision Medicine, by Country USD Million (2019-2024)
  • Table 284. MEA Precision Medicine, by Type USD Million (2019-2024)
  • Table 285. MEA Precision Medicine, by Application USD Million (2019-2024)
  • Table 286. MEA Precision Medicine, by End User USD Million (2019-2024)
  • Table 287. MEA Precision Medicine, by Technology USD Million (2019-2024)
  • Table 288. MEA Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 289. Middle East Precision Medicine, by Type USD Million (2019-2024)
  • Table 290. Middle East Precision Medicine, by Application USD Million (2019-2024)
  • Table 291. Middle East Precision Medicine, by End User USD Million (2019-2024)
  • Table 292. Middle East Precision Medicine, by Technology USD Million (2019-2024)
  • Table 293. Middle East Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 294. Africa Precision Medicine, by Type USD Million (2019-2024)
  • Table 295. Africa Precision Medicine, by Application USD Million (2019-2024)
  • Table 296. Africa Precision Medicine, by End User USD Million (2019-2024)
  • Table 297. Africa Precision Medicine, by Technology USD Million (2019-2024)
  • Table 298. Africa Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 299. North America Precision Medicine, by Country USD Million (2019-2024)
  • Table 300. North America Precision Medicine, by Type USD Million (2019-2024)
  • Table 301. North America Precision Medicine, by Application USD Million (2019-2024)
  • Table 302. North America Precision Medicine, by End User USD Million (2019-2024)
  • Table 303. North America Precision Medicine, by Technology USD Million (2019-2024)
  • Table 304. North America Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 305. United States Precision Medicine, by Type USD Million (2019-2024)
  • Table 306. United States Precision Medicine, by Application USD Million (2019-2024)
  • Table 307. United States Precision Medicine, by End User USD Million (2019-2024)
  • Table 308. United States Precision Medicine, by Technology USD Million (2019-2024)
  • Table 309. United States Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 310. Canada Precision Medicine, by Type USD Million (2019-2024)
  • Table 311. Canada Precision Medicine, by Application USD Million (2019-2024)
  • Table 312. Canada Precision Medicine, by End User USD Million (2019-2024)
  • Table 313. Canada Precision Medicine, by Technology USD Million (2019-2024)
  • Table 314. Canada Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 315. Mexico Precision Medicine, by Type USD Million (2019-2024)
  • Table 316. Mexico Precision Medicine, by Application USD Million (2019-2024)
  • Table 317. Mexico Precision Medicine, by End User USD Million (2019-2024)
  • Table 318. Mexico Precision Medicine, by Technology USD Million (2019-2024)
  • Table 319. Mexico Precision Medicine, by Sequencing USD Million (2019-2024)
  • Table 320. Research Programs/Design for This Report
  • Table 321. Key Data Information from Secondary Sources
  • Table 322. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Precision Medicine: by Type USD Million (2013-2018)
  • Figure 5. Global Precision Medicine: by Application USD Million (2013-2018)
  • Figure 6. Global Precision Medicine: by Sequencing USD Million (2013-2018)
  • Figure 7. South America Precision Medicine Share (%), by Country
  • Figure 8. Asia Pacific Precision Medicine Share (%), by Country
  • Figure 9. Europe Precision Medicine Share (%), by Country
  • Figure 10. MEA Precision Medicine Share (%), by Country
  • Figure 11. North America Precision Medicine Share (%), by Country
  • Figure 12. Global Precision Medicine share by Players 2018 (%)
  • Figure 13. Global Precision Medicine share by Players (Top 3) 2018(%)
  • Figure 14. Global Precision Medicine share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Biocrates Life Sciences AG (Austria) Revenue, Net Income and Gross profit
  • Figure 17. Biocrates Life Sciences AG (Austria) Revenue: by Geography 2018
  • Figure 18. Nanostring Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 19. Nanostring Technologies (United States) Revenue: by Geography 2018
  • Figure 20. Intomics (Denmark) Revenue, Net Income and Gross profit
  • Figure 21. Intomics (Denmark) Revenue: by Geography 2018
  • Figure 22. Pfizer Inc. (united States) Revenue, Net Income and Gross profit
  • Figure 23. Pfizer Inc. (united States) Revenue: by Geography 2018
  • Figure 24. Eagle Genomics Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Eagle Genomics Ltd (United Kingdom) Revenue: by Geography 2018
  • Figure 26. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Teva Pharmaceuticals (Israel) Revenue: by Geography 2018
  • Figure 28. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 29. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2018
  • Figure 30. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Novartis AG (Switzerland) Revenue: by Geography 2018
  • Figure 32. Qiagen NV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Qiagen NV (Netherlands) Revenue: by Geography 2018
  • Figure 34. Quest Diagnostics Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 35. Quest Diagnostics Incorporated (United States) Revenue: by Geography 2018
  • Figure 36. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2018
  • Figure 38. Global Precision Medicine: by Type USD Million (2019-2024)
  • Figure 39. Global Precision Medicine: by Application USD Million (2019-2024)
  • Figure 40. Global Precision Medicine: by Sequencing USD Million (2019-2024)
  • Figure 41. South America Precision Medicine Share (%), by Country
  • Figure 42. Asia Pacific Precision Medicine Share (%), by Country
  • Figure 43. Europe Precision Medicine Share (%), by Country
  • Figure 44. MEA Precision Medicine Share (%), by Country
  • Figure 45. North America Precision Medicine Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Biocrates Life Sciences AG (Austria)
  • Nanostring Technologies (United States)
  • Intomics (Denmark)
  • Pfizer Inc. (united States)
  • Eagle Genomics Ltd (United Kingdom)
  • Teva Pharmaceuticals (Israel)
  • Laboratory Corporation of America Holdings (United States)
  • Novartis AG (Switzerland)
  • Qiagen NV (Netherlands)
  • Quest Diagnostics Incorporated (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
Additional players considered in the study are as follows:
Medtronic (Dublin)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation